Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility
Background Several new genes and clinical subtypes have been identified since the
publication in 2014 of the report of the last International Consensus Meeting on …
publication in 2014 of the report of the last International Consensus Meeting on …
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease
DN Cooper, M Krawczak, C Polychronakos… - Human genetics, 2013 - Springer
Some individuals with a particular disease-causing mutation or genotype fail to express
most if not all features of the disease in question, a phenomenon that is known as 'reduced …
most if not all features of the disease in question, a phenomenon that is known as 'reduced …
From structure to phenotype: impact of collagen alterations on human health
L Arseni, A Lombardi, D Orioli - International journal of molecular sciences, 2018 - mdpi.com
The extracellular matrix (ECM) is a highly dynamic and heterogeneous structure that plays
multiple roles in living organisms. Its integrity and homeostasis are crucial for normal tissue …
multiple roles in living organisms. Its integrity and homeostasis are crucial for normal tissue …
Basement membrane collagens and disease mechanisms
Basement membranes (BMs) are specialised extracellular matrix (ECM) structures and
collagens are a key component required for BM function. While collagen IV is the major BM …
collagens are a key component required for BM function. While collagen IV is the major BM …
Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa
N Dang, DF Murrell - Experimental dermatology, 2008 - Wiley Online Library
Dystrophic epidermolysis bullosa (DEB) is inherited in both an autosomal dominant DEB
and autosomal recessive manner RDEB, both of which result from mutations in the type VII …
and autosomal recessive manner RDEB, both of which result from mutations in the type VII …
Molecular therapeutics in development for epidermolysis bullosa: update 2020
Epidermolysis bullosa (EB) is a group of rare genetic disorders for which significant progress
has been achieved in the development of molecular therapies in the last few decades. Such …
has been achieved in the development of molecular therapies in the last few decades. Such …
Unraveling the ECM-immune cell crosstalk in skin diseases
The extracellular matrix (ECM) is a complex network of proteins and proteoglycans secreted
by keratinocytes, fibroblasts and immune cells. The function of the skin ECM has expanded …
by keratinocytes, fibroblasts and immune cells. The function of the skin ECM has expanded …
Clinical applications of non-antimicrobial tetracyclines in dermatology
E Monk, A Shalita, DM Siegel - Pharmacological Research, 2011 - Elsevier
There are many proposed non-antimicrobial actions of tetracyclines. Pathways affected by
these medications are often overexpressed in various dermatologic conditions. Matrix …
these medications are often overexpressed in various dermatologic conditions. Matrix …
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
A Nyström, L Bruckner-Tuderman, D Kiritsi - Frontiers in Genetics, 2021 - frontiersin.org
The phenotypic presentation of monogenetic diseases is determined not only by the nature
of the causative mutations but also is influenced by manifold cellular, microenvironmental …
of the causative mutations but also is influenced by manifold cellular, microenvironmental …
Understanding the role of ETS-mediated gene regulation in complex biological processes
VJ Findlay, AC LaRue, DP Turner, PM Watson… - Advances in cancer …, 2013 - Elsevier
Ets factors are members of one of the largest families of evolutionarily conserved
transcription factors, regulating critical functions in normal cell homeostasis, which when …
transcription factors, regulating critical functions in normal cell homeostasis, which when …